Resources

Special Report: Top Pharma Predictions for 2016

The pharma industry is undergoing momentous changes with the advance of technology, and is always under pressure to balance the cost and the time that it takes to bring new drugs to market versus the rising costs the public experiences.

In this climate, InCrowd conducted a real time microsurvey of 52 physicians, 7 managed care executives, and 59 pharmacists to help the industry better understand what trends and sentiments are ahead in 2016.

Our findings revealed some key takeaways around drug prices, pharmacy reimbursement, and patient-oriented care.

  • Over two-thirds of respondents want to see lower prices but predict no change, or perhaps higher prices for their patients.
  • 34% of respondents say they want better price controls, whereas 3% predict that’s actually what will happen.
  • Over half of pharmacists want better pharmacy reimbursement, but half of these respondents expect lower reimbursements or no change.
  • The trend was similar for patient-oriented care.

Download our report to read the full findings.

 

Please fill out the form below to access this content

Related Resources

Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more
Dobbs Decision After 18-Months 

Dobbs Decision After 18-Months 

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb's decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the...

read more